2023 annual financial data

Propanc Biopharma 2023 Financial results

Propanc Biopharma 2023 financial results with verified reported values.

Direct answer

Revenue was 0 USD.

Operating income was -1,777,000 USD and net income was -2,661,000 USD.
Operating cash flow was -1,105,251 USD.

Get free Propanc Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-1,777,000 USD
Net income
-2,661,000 USD
Operating cash flow
-1,105,251 USD